Search Results
Results found for "Cancer Research UK"
- 📰 GPCR Weekly News, October 23 to 29, 2023
Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies Methods & Updates in GPCR Research Pharmaceuticals Senior Director, In vitro pharmacology - Crinetics Pharmaceuticals In vivo Antibody Discovery Research
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Research using techniques like bioluminescence resonance energy transfer (BRET) and fluorescence resonance In summary, dimerization in class B1 GPCRs is an emerging area of research that has far-reaching implications
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous Nobel laureate Robert Lefkowitz, M.D., has 50 years of experience with the target and analogizes the search
- Adhesion GPCR Consortium Newsletter - May 2024
Investigación y de Estudios Avanzados del IPN (Cinvestav) How did you become involved in adhesion GPCR research What challenges will researchers overcome in the next 10 years? AB: The next workshop will likely bring together some of the hottest adhesion GPCR research going on
- Dr. Adriano Marchese - Dr. GPCR Podcast
Learn about his remarkable career and research in #GPCR signaling and trafficking.
- Michel Bouvier appointed Knight of the Ordre national du Québec
Michel Bouvier, Chief Executive Officer of IRIC, Principal Investigator of the Molecular Pharmacology Research
- GPCR Therapeutics Expands Scientific Advisory Board
Jon Wigginton will provide scientific expertise to support the company’s research and clinical development
- Domain Therapeutics Raises $42m Series A Financing
STRASBOURG, France & MONTREAL- Domain Therapeutics, a biopharmaceutical company specializing in the research
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
The Hidden Lever in GPCR Research In GPCR pharmacology, the conversation often centers on ligand properties—affinity By reducing receptor density, researchers can transform full agonists into partial ones—allowing comparative
- Community guidelines for GPCR ligand bias: IUPHAR review 32
The guidelines will aid consistency and clarity, as the basic receptor research and drug discovery communities
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
Previous research showed that activation of Gq/11 proteins by G-protein coupled receptors has pro-nociceptive
- 📰 GPCR Weekly News, June 19 to 25, 2023
Methods & Updates in GPCR Research A coiled-coil-based design strategy for the thermostabilization of the Gliovascular Unit of Glioblastoma Associate Director / Director, Clinical Operations Postdoctoral Research
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
The research of GPCRs in the cochlea is essential for the understanding of the cochlea development, hearing
- 📰 GPCR Weekly News, March 13 to 19, 2023
Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Congress of Basic and Clinical Pharmacology GPCR Jobs HIGHLIGHT Senior Scientist, GPCR Pharmacology Research co-transmission sets the activity pattern in the C. elegans egg-laying circuit Methods & Updates in GPCR Research
- Pharmacology at Your Fingertips: Terry’s Corner Launches
GPCR partner Celtarys Research has validated a TR-FRET assay for cannabinoid receptor ligands using their
- C3aR plays both sides in regulating resistance to bacterial infections
Specifically, previous research has identified mechanistically distinct and cell type–specific roles
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
importance of functional selectivity/biased signaling has led to the discovery of biased compounds as both research
- 📰 GPCR Weekly News, January 16 to 22, 2023
Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news Methods & Updates in GPCR Research Mapping of structural arrangement of cells and collective calcium
- 📰 GPCR Weekly News - January 9 to 15, 2023
Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news first-line treatment The Lundbeck Foundation is awarding DKK 174 million in grants to seven ‘mind-bending’ research
- Immunomodulatory Role of Neuropeptides in the Cornea
As research in this area expands, further insights are made into the role of neuropeptides and their
- SLAS2022 International Conference and Exhibition
Don't miss the chance to present your innovative research at this year's conference.
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
matters: Allosteric inhibitors often retain potency under high substrate conditions, such as ATP-rich cancer
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Cannabinoids as Anticancer Drugs: Current Status of Preclinical Research. Br J Cancer 2022 , 127 (1), 1–13. https://doi.org/10.1038/s41416-022-01727-4 . (4) Hua, T. Nucleic Acids Research 2021 , 49 (12), e72–e72. https://doi.org/10.1093/nar/gkab237 . (20) Degorce
- 4GPCRnet - International Symposium
Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded
- Comparative study of neuropeptide signaling systems in Hemiptera
This research provides more knowledge on neuropeptide systems and sets the groundwork for the creation
- All About Addgene: More Open and Reproducible Science with Materials Sharing
If you need a plasmid for your research or you want to share your materials, this is the place to go.
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
Matt Barnes appointed President of Heptares Therapeutics Ltd., and Head of UK R&D Tokyo, Japan and Cambridge , UK, 24 March 2022 – Sosei Group Corporation (“the Company”; TSE: 4565) today confirms that a series
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
In 2007 he formed IndiPharm which was a full-service Contract Research Organization whose operational
- Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused...
hypercalcemia caused by biased allosteric CaSR autoantibodies "Biased agonism is a frontier field in GPCR research








